期刊文献+

颈动脉加压注射瘫康灵治疗偏瘫的临床研究 被引量:1

Clinical Study on the Treatment of Hemiparalysis with Carotid Artery Pressure Injection of Tankangling(TKL)
暂未订购
导出
摘要 目的:探讨颈动脉加压注射瘫康灵治疗偏瘫患者的临床疗效。方法:将216例偏瘫患者随机分为2组,治疗组采用颈动脉加压注射瘫康灵治疗,对照组采用常规治疗,两组在治疗前、后对功能缺损评分、血粘度、有效率、治愈率进行对比分析。结果:治疗组与对照组在功能缺损评分、血粘度、有效率、治愈率方面均有显著差异(P<0.01)。结论:颈动脉加压注射瘫康灵是治疗偏瘫的有效方法。 Objective: To discuss the clinic effect on the treatment of hemiparalysis patients in a mode of the carotid artery pressure injection of Tankangling (TKL). Methods: Use the stochastic grouping comparision research, 216 cases of hemiparalysis patients were allocated randomly into two groups:treatment group and control group(108 cases in every group). The treatment group was given injection of TKL in the mode of carotid artery pressure, the changes of the neurological deficit scores, blood viscosity, effectiveness and cure rate after treatment were observed in both groups. Results: There were significant differences in the total cure rate,effectiveness, blood viscosity and the neureological deficit scores between the treatment group and the control group(P〈0. 001). Conclusion: The pressure injection of TKL in the mode of carotid artery is very effect to the hemiparalysis patients.
出处 《医学理论与实践》 2006年第10期1125-1127,共3页 The Journal of Medical Theory and Practice
基金 江苏省常州市武进区科技发展(社会发展)基金项目(050709)
关键词 偏瘫 颈动脉加压注射 瘫康灵 Hemiparalysis, Carotid artery pressure injection, Tankangling(TKL)
  • 相关文献

参考文献4

二级参考文献32

  • 1匡培根,陶沂,田亚平,石晶.巴曲酶对大鼠缺血再灌注损伤的保护作用─—降低NO神经毒性作用[J].临床神经病学杂志,1995,8(6):329-331. 被引量:85
  • 2匡培根,彭超英,陶沂,于生元,吴卫平,郎森阳,管维平,蒲传强,王国平,朱克,徐波,马维亚,张小澍,袁玉民.巴曲酶速控频发的短暂脑缺血发作──多中心随机对照研究[J].脑与神经疾病杂志,1996,4(2):65-70. 被引量:67
  • 3杨靖华.蛇毒酶在缺血性脑血管疾病中的应用[J].国外医学(脑血管疾病分册),1996,4(3):141-145. 被引量:80
  • 4刘凤君 陈清棠 等.东菱克栓酶对缺血性脑血管病血液流变学的影响[J].中国医学论坛,1995,10:19-19.
  • 5冯加纯 丁箭 等.东菱克栓酶治疗脑梗塞27例观察[J].中风与神经疾病杂志,1995,12:111-111.
  • 6吴卫平 李振洲 等.脑缺血再灌后脑组织C-fos基因表达与东菱克栓酶的影响[J].中风与神经疾病杂志,1995,12:73-73.
  • 7沈国柱 范明芳 等.梗塞患者血清中LPO、SOD水平与巴曲酶的影响[J].临床神经病学杂志,1997,10:15-15.
  • 8Dempfle CE, Argkiou S, Aiesci S, et al. Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibm formation and thrombh kadependent factor ⅩⅢ activity. Ann N YAcad Sci, 2001, 936:210 -214.
  • 9Prentice CR, Hampton KK, G-rant PJ, et aL The fibrmolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products. Br J Haematol, 1993, 83:276 -281.
  • 10Izumi Y, Tsuda Y, Ichihara S, et al. Effects of defibrhaation on hemorhoology, cerebral blood flow velocity, and CO2 reactivity during hypoeapnia ha normal subjects. Stroke, 1996, 27:1328 - 1332.

共引文献15894

同被引文献25

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部